A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent

January 27, 2022 updated by: Sang Hyub Lee, Seoul National University Hospital

A Comparison of a Fully Covered Self-expandable Metal Stent With an External Anchoring Plastic Stent and Uncovered Stent: Prospective Randomized Multicenter Study

Multi-center, randomized controlled study fc-SEMS with anchoring plastic stent vs uc-SEMS in malignant biliary obstruction

Study Overview

Detailed Description

This study is multi-center, randomized controlled study to compare the stent patency in malignant biliary obstruction. The patency of fully covered self expandable metal stent with external anchoring plastic stent was compared with that of uncovered self expandable metal stent.

Study Type

Interventional

Enrollment (Anticipated)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 03080
        • Recruiting
        • Seoul National University Hospital
        • Contact:
          • Sang Hyub Lee, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults with 19 years of age or older
  • Those who voluntarily consented to the trial and signed a written consent
  • Inoperable malignant biliary obstruction

Exclusion Criteria:

  • Previous surgical biliary drainage
  • Patients continuosly requiring percutaneous transhepatic biliary drainage
  • History of biliary drainage with metal stent
  • Biliary obstruction located in hilum or intrahepatic duct
  • Patients with life expectancy of 3 months or less
  • On pregnancy
  • Unable to underwent endoscopic procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: fc-SEMS with anchoring plastic stent
fully covered self-expanable metal stent with an external anchoring plastic stent
Extrahepatic malignant biliary obstruction treated with fully covered self-expandable metal stent with an anchoring plastic stent
Active Comparator: uc-SEMS
uncovered self-expandable metal stent
Extrahepatic malignant biliary obstruction treated with uncovered self-expandable metal stent without an anchoring plastic stent

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of patent stent
Time Frame: 1 year
The number of patient without stent dysfuction divided by total number of patients
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stent obstruction
Time Frame: 1 year
Suspected by jaundice (Total bilirubin > 2 upper normal limit) or radiologic finding of stent occlusion which is confirmed by ERCP
1 year
Stent migration
Time Frame: 1 year
Radiologic finding of migration through Abdomen X-ray or CT scan
1 year
Re-intervention
Time Frame: 1 year
Endoscopic retrograde biliary drainage or Percutaneous transhepatic biliary drainage
1 year
Adverse event
Time Frame: 1 year
acute cholangitis, acute cholecystitis, acute pancreatitis
1 year
Overall survival
Time Frame: 1 year
Timespan from the diagnosis to the death
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 25, 2021

Primary Completion (Anticipated)

October 24, 2023

Study Completion (Anticipated)

October 24, 2024

Study Registration Dates

First Submitted

January 4, 2022

First Submitted That Met QC Criteria

January 27, 2022

First Posted (Actual)

February 2, 2022

Study Record Updates

Last Update Posted (Actual)

February 2, 2022

Last Update Submitted That Met QC Criteria

January 27, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malignant Biliary Obstruction

Clinical Trials on fully covered self-expandable metal stent with an anchoring external plastic stent

3
Subscribe